These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit. Su MZ; Campbell NA; Lau HM Transplantation; 2014 Mar; 97(6):654-9. PubMed ID: 24212503 [TBL] [Abstract][Full Text] [Related]
24. Partial nephrectomy in two patients with known T3a tumours involving the renal vein. Kim EH; Jain S; Benway BM; Figenshau RS BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846 [TBL] [Abstract][Full Text] [Related]
25. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Rombouts SJ; Vogel JA; van Santvoort HC; van Lienden KP; van Hillegersberg R; Busch OR; Besselink MG; Molenaar IQ Br J Surg; 2015 Feb; 102(3):182-93. PubMed ID: 25524417 [TBL] [Abstract][Full Text] [Related]
30. A Rare Case of Donor-Derived Renal Cell Carcinoma in a Kidney Transplant Recipient. Sebastian W; Omar KO; Anees R; Nagaraju S; Chaitanya M Am J Case Rep; 2024 Mar; 25():e941214. PubMed ID: 38442088 [TBL] [Abstract][Full Text] [Related]
31. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357 [TBL] [Abstract][Full Text] [Related]
32. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study). Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201 [TBL] [Abstract][Full Text] [Related]
33. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial. Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653 [TBL] [Abstract][Full Text] [Related]
34. Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses. Dib RE; Touma NJ; Kapoor A Can Urol Assoc J; 2009 Apr; 3(2):143-9. PubMed ID: 19424470 [TBL] [Abstract][Full Text] [Related]
35. Laparoscopic high-intensity focused ultrasound for renal tumours: a proof of concept study. Ritchie RW; Leslie TA; Turner GD; Roberts IS; D'Urso L; Collura D; Demarchi A; Muto G; Sullivan ME BJU Int; 2011 Apr; 107(8):1290-6. PubMed ID: 21929519 [TBL] [Abstract][Full Text] [Related]
36. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890 [TBL] [Abstract][Full Text] [Related]
37. Update on ablative therapies of renal tumors. D'Andrea D; Shariat SF; Klatte T Curr Opin Urol; 2016 Sep; 26(5):410-6. PubMed ID: 27214581 [TBL] [Abstract][Full Text] [Related]
38. Extracorporeal organotripsy for renal tumours. Häcker A; Michel MS; Koehrmann KU Curr Opin Urol; 2003 May; 13(3):221-5. PubMed ID: 12692445 [TBL] [Abstract][Full Text] [Related]
39. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review. Allen D; Gillen E; Rixson L JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426 [TBL] [Abstract][Full Text] [Related]